Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,442 | 104,765 | 167,467 | 171,532 | 59,064 |
| Marketable Securities | 28,540 | 61,038 | 34,837 | 72,949 | 27,220 |
| Receivables | 1,756 | 1,765 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 1,694 | 1,771 | 2,292 |
| TOTAL | $152,630 | $173,644 | $211,392 | $252,305 | $91,945 |
| Non-Current Assets | |||||
| PPE Net | 10,299 | 10,950 | 11,353 | 12,062 | 11,994 |
| Other Non-Current Assets | 18,053 | 20,729 | 21,741 | 20,358 | 22,295 |
| TOTAL | $28,352 | $31,679 | $33,094 | $32,420 | $34,289 |
| Total Assets | $180,982 | $205,323 | $244,486 | $284,725 | $126,234 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,667 | N/A | N/A | 6,667 |
| Accounts payable and accrued liabilities | 6,693 | 2,795 | 6,411 | 13,017 | 6,124 |
| Accrued Expenses | 17,328 | 13,749 | 17,966 | 21,713 | 20,479 |
| TOTAL | $28,375 | $23,551 | $30,778 | $38,424 | $38,927 |
| Non-Current Liabilities | |||||
| Long Term Debt | 40,930 | 39,117 | 40,649 | 40,514 | 33,968 |
| Deferred Revenues | 2,185 | 3,245 | 4,330 | 1,625 | 3,591 |
| Other Non-Current Liabilities | 38,438 | 35,902 | 45,323 | 76,613 | 22,312 |
| TOTAL | $79,368 | $75,019 | $85,972 | $117,130 | $56,288 |
| Total Liabilities | $107,743 | $98,570 | $116,750 | $155,554 | $95,215 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,710 | 20,596 | 20,300 | 20,226 | 6,301 |
| Common Shares | 20 | 20 | 20 | 20 | 62 |
| Retained earnings | -618,280 | -582,022 | -558,233 | -553,459 | -523,206 |
| Other shareholders' equity | 49 | 263 | 102 | -226 | -313 |
| TOTAL | $73,239 | $106,753 | $127,736 | $129,171 | $31,019 |
| Total Liabilities And Equity | $180,982 | $205,323 | $244,486 | $284,725 | $126,234 |